{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:17:28Z","timestamp":1772180248852,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T00:00:00Z","timestamp":1192579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001044","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T12:06:30Z","timestamp":1193227590000},"page":"e1044","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Complement C3d Conjugation to Anthrax Protective Antigen Promotes a Rapid, Sustained, and Protective Antibody Response"],"prefix":"10.1371","volume":"2","author":[{"given":"Ravi V.","family":"Kolla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Chintalapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Santelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Liddington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Fierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Guiney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Rickert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,10,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","article-title":"Molecular basis for improved anthrax vaccines.","volume":"57","author":"RN Brey","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"ref2","first-page":"341","article-title":"Surveillance for adverse events associated with anthrax vaccination\u2013U.S. Department of Defense, 1998\u20132000.","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pds.712","article-title":"Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).","volume":"11","author":"JL Sever","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax.","volume":"110","author":"SH Leppla","year":"2002","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","article-title":"Current status of immunization against anthrax: old vaccines may be here to stay for a while.","volume":"13","author":"PC Turnbull","year":"2000","journal-title":"Curr Opin Infect Dis"},{"key":"ref6","first-page":"265 p","article-title":"The Anthrax Vaccine: Is It Safe? Does It Work?","year":"2002"},{"key":"ref7","first-page":"RA276","article-title":"Anthrax\u2013an overview.","volume":"9","author":"S Oncu","year":"2003","journal-title":"Med Sci Monit"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax.","volume":"55","author":"M Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection.","volume":"23","author":"DJ Chabot","year":"2004","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor.","volume":"430","author":"E Santelli","year":"2004","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2672.1999.00888.x","article-title":"Crystallographic studies of the anthrax lethal toxin.","volume":"87","author":"R Liddington","year":"1999","journal-title":"J Appl Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen.","volume":"385","author":"C Petosa","year":"1997","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2004.10.014","article-title":"Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.","volume":"23","author":"I Berthold","year":"2005","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/S0264-410X(03)00109-9","article-title":"Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.","volume":"21","author":"S Jendrek","year":"2003","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines.","volume":"82","author":"EB Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.","volume":"271","author":"PW Dempsey","year":"1996","journal-title":"Science"},{"key":"ref17","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial.","author":"GJ Gorse","year":"2006","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.virol.2005.06.034","article-title":"Characterization of antibody responses to purified HIV-1 gp120 glycoproteins fused with the molecular adjuvant C3d.","volume":"340","author":"M Koch","year":"2005","journal-title":"Virology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-2427(01)00369-5","article-title":"Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization.","volume":"83","author":"S Suradhat","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0264-410X(01)00266-3","article-title":"C3d enhancement of neutralizing antibodies to measles hemagglutinin.","volume":"20","author":"TD Green","year":"2001","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1074-7613(02)00483-1","article-title":"Complement receptors CD21\/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses.","volume":"17","author":"KM Haas","year":"2002","journal-title":"Immunity"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.4049\/jimmunol.172.10.5833","article-title":"Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21\/35 expression.","volume":"172","author":"KM Haas","year":"2004","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4049\/jimmunol.159.3.1557","article-title":"Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21):.","volume":"159","author":"K Takahashi","year":"1997","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.160.6.2619","article-title":"Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice.","volume":"160","author":"MB Fischer","year":"1998","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.160.11.5273","article-title":"Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG.","volume":"160","author":"Y Fang","year":"1998","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-1759(01)00471-9","article-title":"Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function.","volume":"258","author":"SE Henson","year":"2001","journal-title":"Journal of Immunological Methods"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.167.1.163","article-title":"The role of the CD19\/CD21 complex in B cell processing and presentation of complement-tagged antigens.","volume":"167","author":"A Cherukuri","year":"2001","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood.V95.8.2617","article-title":"Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21).","volume":"95","author":"MW Hess","year":"2000","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.4049\/jimmunol.175.8.5379","article-title":"A critical role for complement C3d and the B cell coreceptor (CD19\/CD21) complex in the initiation of inflammatory arthritis.","volume":"175","author":"CJ Del Nagro","year":"2005","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1574-695X.2006.00096.x","article-title":"Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages.","volume":"47","author":"M Sabet","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/IAI.73.11.7535-7540.2005","article-title":"MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling.","volume":"73","author":"MA Hughes","year":"2005","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection.","volume":"70","author":"HC Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody.","volume":"278","author":"MJ Rosovitz","year":"2003","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1042\/bst0300983","article-title":"Structure of complement receptor (CR) 2 and CR2-C3d complexes.","volume":"30","author":"J Hannan","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.coi.2005.03.001","article-title":"Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.","volume":"17","author":"RC Rickert","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.","volume":"191","author":"JA Mikszta","year":"2005","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0952-7915(97)80160-4","article-title":"Complement and the immune response.","volume":"9","author":"MC Carroll","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.4049\/jimmunol.162.12.7198","article-title":"IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.","volume":"162","author":"AM Oliver","year":"1999","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.coi.2005.04.007","article-title":"The primary germinal center response in mice.","volume":"17","author":"CL Cozine","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0264-410X(02)00169-X","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants.","volume":"20","author":"H HogenEsch","year":"2002","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by Toll-like receptors.","volume":"438","author":"C Pasare","year":"2005","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature04875","article-title":"Immunology: Toll-like receptors and antibody responses.","volume":"441","author":"D Nemazee","year":"2006","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1089926","article-title":"Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population.","volume":"304","author":"MB Jordan","year":"2004","journal-title":"Science"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T09:54:40Z","timestamp":1684058080000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001044"}},"subtitle":[],"editor":[{"given":"Niyaz","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,17]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001044","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1091539.546021","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,17]]}}}